| Authors: |
Kavanagh ME; Department of Chemistry, Scripps Research, La Jolla, CA, USA., Horning BD; Vividion Therapeutics, San Diego, CA, USA., Khattri R; Vividion Therapeutics, San Diego, CA, USA., Roy N; Vividion Therapeutics, San Diego, CA, USA., Lu JP; Vividion Therapeutics, San Diego, CA, USA., Whitby LR; Vividion Therapeutics, San Diego, CA, USA., Ye E; Department of Chemistry, Scripps Research, La Jolla, CA, USA., Brannon JC; Vividion Therapeutics, San Diego, CA, USA., Parker A; Vividion Therapeutics, San Diego, CA, USA., Chick JM; Vividion Therapeutics, San Diego, CA, USA., Eissler CL; Vividion Therapeutics, San Diego, CA, USA., Wong AJ; Vividion Therapeutics, San Diego, CA, USA., Rodriguez JL; Vividion Therapeutics, San Diego, CA, USA., Rodiles S; Vividion Therapeutics, San Diego, CA, USA., Masuda K; Department of Chemistry, Scripps Research, La Jolla, CA, USA., Teijaro JR; Department of Immunology and Microbial Science, Scripps Research, La Jolla, CA, USA., Simon GM; Vividion Therapeutics, San Diego, CA, USA., Patricelli MP; Vividion Therapeutics, San Diego, CA, USA. mattp@vividion.com., Cravatt BF; Department of Chemistry, Scripps Research, La Jolla, CA, USA. cravatt@scripps.edu. |
